Bacteremia due to viridans group streptococi with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis

Clinical Infectious Diseases

Volumn 34, Issue 11, 2002, Pages 1469-1474

  Razonable, Raymund R ^a   Litzow, Mark R ^a   Khaliq, Yasmin ^a   Piper, Kerryl E ^a   Rouse, Mark S ^a   Patel, Robin ^a,b  

^a MAYO CLINIC   (United States)

^b Division of Clinical Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CLINICAL ARTICLE; FEMALE; FEVER; GENE MUTATION; HUMAN; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEPTIC SHOCK; STEM CELL TRANSPLANTATION;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; CHEMOPREVENTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEUTROPENIA; OFLOXACIN; STREPTOCOCCUS;

EID: 0036604492     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340352     Document Type: Article

References (28)

1. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
2. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer
3. Viridans streptococcal shock in bone marrow transplantation patients
4. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients
5. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: Effect of augmented gram-positive activity on infectious morbidity
6. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients
7. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis
8. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation
9. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: Data from the SENTRY Antimicrobial Surveillance Program
10. Potencies of newer fluoroquinolones against viridans group streptococci isolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada!
11. Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers
12. Streptococcus
13. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients
14. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci
15. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in Streptococcus mitis
16. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci
17. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci
18. Trovafloxacin treatment of viridans group streptococcus experimental endocarditis
19. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus
20. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
21. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones
22. Mechanisms of action of antimicrobials: Focus on fluoroquinolones
23. Bacteremia due to viridans streptococci in neutropenic patients: A review
24. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
25. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice
26. Emergence of vancomycin tolerance in Streptococcus pneumoniae
27. Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pueumoniae